Selected article for: "human population and specific population"
Author: Li, Dan-Dan; Li, Qi-Han
Title: SARS-CoV-2: vaccines in the pandemic era
  • Cord-id: xde10g9v
  • Document date: 2021_1_6
    • ID: xde10g9v
    Snippet: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused millions of infections and deaths worldwide since its emergence in December 2019. As there is little or no natural immunity in the human population or specific anti-COVID-19 drugs, researchers from the government, academia and industry are developing vaccines at an unprecedented speed to halt the pandemic. In this review, the results of animal experiments and clinical trial
    Document: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused millions of infections and deaths worldwide since its emergence in December 2019. As there is little or no natural immunity in the human population or specific anti-COVID-19 drugs, researchers from the government, academia and industry are developing vaccines at an unprecedented speed to halt the pandemic. In this review, the results of animal experiments and clinical trials on several vaccine technical platforms are summarized, and several challenges are also discussed to further promote the development, evaluation and application of vaccines during the challenging situation of the global pandemic.

    Search related documents:
    Co phrase search for related documents
    • abnormal change and acute respiratory syndrome coronavirus: 1
    • acute infectious disease and address need: 1
    • acute pneumonia and address need: 1
    • acute pneumonia and ade antibody dependent enhancement: 1, 2
    • acute respiratory syndrome coronavirus and address need: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and address need issue: 1
    • acute respiratory syndrome coronavirus and ade antibody dependent enhancement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and ade evidence: 1